Cencora
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale company and a contract research organization that was formed by the merger of Bergen Brunswig and AmeriSource in 2001.
Formerly | AmerisourceBergen Corporation (2001–2023) |
---|---|
Company type | Public |
Traded as |
|
Industry | Pharmaceutical |
Founded | 2001 | (merger between AmeriSource Health and Bergen Brunswig)
Headquarters | |
Area served |
|
Key people | Richard C. Gozon (Chairman) Steven H. Collis (President & CEO) |
Products | Pharmaceuticals and pharmacy services |
Revenue | US$262 billion (2023) |
US$2.34 billion (2023) | |
Net income | US$1.75 billion (2023) |
Total assets | US$62.6 billion (2023) |
Total equity | US$522 million (2023) |
Owner | Walgreens Boots Alliance (25%) |
Number of employees | c. 46,000 (2023) |
Website | cencora |
Footnotes / references Financials as of September 30, 2023. |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.